mission statement is “to create an
innovation-driven, patient-focused specialty biopharmaceutical company capable
of achieving sustainable top-tier performance through outstanding execution and
a consistent stream of innovative new medicines.” The mission statement
indicates the primary roles of the company when it comes to its line of
business. It also stamps its leadership influence in the sector and how it
seeks to influence biopharmaceutical changes. The following elements relate to
this mission statement:
lives and communities.
AbbVie mission statement emphasizes on coming up with products that leave a
difference in the lives of people. The company does this by stimulating
development in the line of medicine to address treatment gaps in the healthcare
sector. It also extends this impact to its corporate responsibilities where it
purposes to leave a positive mark in the lives of the people it comes in
contact with through participatory research. Its corporate
responsibility comprehensively explores how AbbVie advances this
component of its mission statement.
healthcare. Coming up
with better indications and medicines remains as the top priority of AbbVie
biopharmaceutical. Through this, the company advances the second component of
its mission statement by striving to create the most impactful medicines to
address the pressing treatment needs in the health sector. AbbVie recognizes
the treatment gaps existing today, and that motivates the company to stay ahead
of the rest when it comes to being creative. By doing so, it makes access and
availability of healthcare simpler through advanced medicines and indications.
The unwavering commitment declared in the therapeutic
focus section of the company is evidence of how important this
component is to the mission of the company.
expectations. The rate
of healthcare advancements prompted by AbbVie efforts tells more about the
company’s desire to achieve this third component in its mission statement.
AbbVie shows that it does not settle for just enough. The persistent support
and resource it commits to innovative research demonstrate its commitment to do
extraordinary. The company does this by being a directive leader to propel
research in critical areas, including the often overlooked ones rather than
merely focusing all its efforts on the pressing needs only. Its innovation
in action is proof that the company not only meets the most critical
needs of the biopharmaceutical sector but also goes ahead to offer much more
mission and vision statement of AbbVie has positioned it as one of the leading
research-based company in the world today. By crafting focusing on dynamic
transformation, AbbVie has gained prominence in the biopharmaceutical niche
with its people-centered research. In fact, its gradual and constant growth is
proof of its consistent in what it does ever since it was founded in in 2013.
Ideally, the vision statement of a company outlines the business position the
firm strives to be in the near future. AbbVie vision focusses on the number
of research breakthroughs its leadership seeks to influence in the
biopharmaceutical sector. In relation to this, the mission statement of a
company comprises of the strategic actions or the critical steps that a company
seeks to take to ensure it advances towards its vision. In this case, AbbVie
emphasizes on top quality research processes that are not only targeted to
impact people but also advance medicines in general. AbbVie has particularly
remained progressive in both its mission and vision statement courtesy of its
strong core values. Values in a company act as the moral principles that
influence all the operations of an establishment to stay within the set
objectives and goals. For AbbVie, its values such as integrity, saving the
community, being diverse and inclusive, and transforming lives are a reflection
of the principles that guide the organization towards its mission and vision
statements. In fact, these three components interrelate so seamlessly that this
is accredited for the continued growth spur recorded in AbbVie Company.
vision statement is “Innovative
medicines provide compelling patient benefits, differentiated clinical
performance, and economic value. We plan to launch 20 new products or
indications by 2020 that elevate the standard of care and address significant
unmet needs.” It explicitly outlines
the milestones the company seeks to achieve within a set timeline while at the
same time prioritizing on innovativeness. Various elements relate to this
mission statement including:
benefits and clinical performance.
Based on AbbVie mission statement, creating products that benefit the
patients through proper clinical performance is a primary strategic objective
of the company. It explains the dynamism characterizing the clinical trials
of the company to ensure it only designs the best medicines and
indications to maximize their benefits on the patients.
value. AbbVie vision
is not all about creating medicines. It ensures that this objective takes into
consideration the economic factor attached to healthcare products. In this way,
it shields itself as well as the patients by ensuring that its innovations are
economic sensitive and affordable as well.
- Innovation. Biopharmaceutical innovation is
essentially the most prominent element in the operations of AbbVie. The
company’s primary focus is advancing healthcare by creating new and better-related
products. In fact, this is clearly detailed in the company’s products
and services section. In this way, the company does more than creating products
– it addresses the unmet needs in the healthcare sector.
core values comprise “transforming lives, acting with integrity, driving
innovations, embracing diversity and inclusion and serving the community.” The
core values describe the guiding principles the company follows to ensure it
stays within the needs of its mission and vision statements. The following
components emerge from the core values:
- Transforming lives
- Acting with integrity
- Driving innovations
- Embracing diversity and inclusion
- Serving the community
AbbVie first component in its values emphasizes on ensuring that all the activities of the company change the lives of people. The focus on interacting and improving people comes out in how AbbVie contributes to communities. It presents a relationship with its second component that demands doing right in all the processes, especially those related to the third component, innovations. In this way, the company makes progress in its service to the community. To ensure AbbVie is a non-discriminatory institution, its core values emphasize on the firm being inclusive as one that embraces diversity.
Abbvie Mission Statement History
Abbvie mission statement remains unchanged through 2020 and 2021
Company – About
Cady, S. H., Wheeler, J. V., DeWolf, J., & Brodke, M. (2011).
Mission, vision, and values: what do they say?. Organization
Development Journal, 29(1).
Darbi, W. P. K. (2012). Of mission and vision statements and their
potential impact on employee behaviour and attitudes: The case of a public but
profit-oriented tertiary institution. International Journal of Business
and Social Science, 3(14).
David, F. R., & David, F. R. (2003). It’s time to redraft your
mission statement. Journal of Business Strategy, 24(1),
Freeman, R. E. (2010). Strategic management: A stakeholder approach.
Cambridge university press.
Jones, R. (2010). Corporate branding: the role of vision in implementing
the corporate brand. Innovative Marketing, 6(1), 44-57.
Khan, H. M. (2015). Biomanufacturing Science and Technology Consortium
to Advance US Manufacturing of Biopharmaceuticals.
Longstaff, C., Whitton, C. M., Stebbings, R., & Gray, E. (2009). How
do we assure the quality of biological medicines?. Drug discovery today, 14(1-2),
Lucas, J. R. (1998). Anatomy of a vision statement. Management
Review, 87(2), 22-27.
Mullane, J. V. (2002). The mission statement is a strategic tool: when
used properly. Management Decision, 40(5), 448-455.
Network, R. C. A. (2016). Vision Statement.
Williams, L. S. (2008). The mission statement. Journal of
business communication, 45(2)